Shares of ultrasound manufacturer Acuson got a major boost frominvestors this month after the Mountain View, CA, company postedfinancial results that saw a 12% increase in fourth-quarter revenues.Acuson said its revenue growth was due to shipments of its
Shares of ultrasound manufacturer Acuson got a major boost frominvestors this month after the Mountain View, CA, company postedfinancial results that saw a 12% increase in fourth-quarter revenues.Acuson said its revenue growth was due to shipments of its newSequoia and Aspen scanners.
For the year (end-December), Acuson posted revenues of $346.2million, up 5% compared with revenues of $328.9 million in 1996.The company recorded a net loss for the year of $10.6 million,compared with net income of $7.1 million the year before.
Acuson's revenue began to grow substantially in the second halfof the year, however, as Aspen and Sequoia shipments ramped up.For the fourth quarter, the company had record revenues of $93.7million, compared with sales of $83.6 million in the same periodthe year before. As Acuson predicted earlier this year, the vendorposted a fourth-quarter net loss of $2.9 million due to start-upcosts related to its product launches. Acuson had net income of$1.9 million in the fourth quarter of 1995.
Investors weren't fazed by the year-end and fourth-quarter losses,and instead found good news in the company's strong revenue growth.Acuson shares rose from around $25 a share before the resultswere released to nearly $29, and were trading at around $28.50last week. That's more than double the company's 52-week low of$12.63 a share.
In other Acuson news, the vendor was named the exclusive providerof radiology and cardiology ultrasound equipment to the Mid-AtlanticGroup Network of Shared Services (MAGNET) of Mechanicsburg, PA.Acuson replaced another ultrasound vendor as MAGNET's sole-sourceprovider, the company said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.